Zusammenfassung
Die körperliche Aktivität ist ein bedeutsamer Parameter der Morbidität und Mortalität für kardiovaskuläre Erkrankungen, das metabolische Syndrom/Diabetes, mentale Erkrankungen, maligne Erkrankungen sowie die chronisch-obstruktive Bronchitis und das Lungenemphysem („chronic obstructive pulmonary disease“ [COPD]). Eine geringere körperliche Aktivität der Patienten mit COPD ist mit einem schnelleren jährlichen Verlust der Lungenfunktion, häufigeren Hospitalisierungen und einem höheren Mortalitätsrisiko assoziiert. Die selbstberichtete körperliche Aktivität von Patienten mit COPD ist nur ungenügend mit deren objektiv gemessener körperlicher Aktivität korreliert. Neuere Untersuchungen zeigen, dass die körperliche Aktivität von Patienten mit COPD verlässlich gemessen werden kann. Extrapulmonale Auswirkungen der COPD sind mit einer geringeren körperlichen Aktivität assoziiert. Klinische Charakteristika zur Schweregradeinteilung der COPD wie das forcierte exspiratorische Volumen in 1 s und der 6-min-Gehtest geben die körperliche Aktivität der Patienten nur unvollständig wieder.
Abstract
Physical activity is an important parameter related to morbidity and mortality in cardiovascular disease, metabolic syndrome/diabetes, mental disorders, cancer, and chronic obstructive pulmonary disease (COPD). In COPD, lower levels of physical activity as reported by the patients are associated with a faster annual lung function decline, increased number of hospitalizations, and higher risk of mortality. Self-reported physical activity, however, correlates only poorly with objectively quantified physical activity in patients with COPD. Recent data show that physical activity can reliably be measured in a substantial number of patients with COPD. Extrapulmonary effects of COPD are associated with reduced physical activity. Clinical characteristics commonly used to assess disease severity like the forced expiratory volume in 1 s or the 6-min walk distance only incompletely reflect the physical activity of patients with COPD.
References
Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003;107:3109–16.
Manini TM, Everhart JE, Patel KV, et al. Daily activity energy expenditure and mortality among older adults. JAMA 2006;296:171–9.
Steele BG, Belza B, Cain K, et al. Bodies in motion: monitoring daily activity and exercise with motion sensors in people with chronic pulmonary disease. J Rehabil Res Dev 2003;40:45–58.
Pitta F, Troosters T, Probst VS, et al. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J 2006;27:1040–55.
Watz H, Waschki B, Meyer T, et al. Physical activity in patients with COPD. Eur Respir J 2009;33:262–72.
Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:Suppl:S498–504
Pate RR, Pratt M, Blair SN, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995;273:402–7.
Bravata DM, Smith-Spangler C, Sundaram V, et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA 2007;298:2296–304.
Tudor-Locke C, Bassett DR Jr. How many steps/day are enough? Preliminary pedometer indices for public health. Sports Med 2004;34:1–8.
Steele BG, Holt L, Belza B, et al. Quantitating physical activity in COPD using a triaxial accelerometer. Chest 2000;117:1359–67.
Pitta F, Troosters T, Spruit MA, et al. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005;86: 1979–85.
Ward DS, Evenson KR, Vaughn A, et al. Accelerometer use in physical activity: best practices and research recommendations. Med Sci Sports Exerc 2005;37:Suppl:S582–8.
Trost SG, McIver KL, Pate RR. Conducting accelerometer-based activity assessments in field-based research. Med Sci Sports Exerc 2005;37:Suppl: S531–43.
Watz H, Waschki B, Boehme C, et al. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008;177:743–51.
Patel SA, Benzo RP, Slivka WA, et al. Activity monitoring and energy expenditure in COPD patients: a validation study. COPD 2007;4:107–12.
Mora S, Cook N, Buring JE, et al. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 2007;116:2110–8.
Ford ES, Kohl HW III, Mokdad AH, et al. Sedentary behavior, physical activity, and the metabolic syndrome among U.S. adults. Obes Res 2005;13:608–14.
Ford ES, Li C. Physical activity or fitness and the metabolic syndrome. Expert Rev Cardiovasc Ther 2006;4:897–915.
Rovio S, Kareholt I, Helkala EL, et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease. Lancet Neurol 2005;4:705–11.
Strawbridge WJ, Deleger S, Roberts RE, et al. Physical activity reduces the risk of subsequent depression for older adults. Am J Epidemiol 2002;156:328–34.
Thune I, Brenn T, Lund E, et al. Physical activity and the risk of breast cancer. N Engl J Med 1997;336:1269–75.
Giovannucci E, Ascherio A, Rimm EB, et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995;122:327–34.
McTiernan A. Mechanisms linking physical activity with cancer. Nat Rev Cancer 2008;8:205–11.
Schönhofer B, Ardes P, Geibel M, et al. Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J 1997;10:2814–9.
Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972–7.
Pitta F, Troosters T, Probst VS, et al. Physical activity and hospitalization for exacerbation of COPD. Chest 2006;129:536–44.
Watz H, Waschki B, Kirsten AM, et al. [Heart failure in chronic obstructive pulmonary disease (COPD).] Dtsch Med Wochenschr 2008;133: 717–9.
Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don’t know (but should). Proc Am Thorac Soc 2007;4:522–5.
Garcia-Aymerich J, Farrero E, Felez MA, et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003;58:100–5.
Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006;61:772–8.
Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007;175:458–63.
Walker PP, Burnett A, Flavahan PW, et al. Lower limb activity and its determinants in COPD. Thorax 2008;63:683–9.
Pitta F, Troosters T, Probst VS, et al. Are patients with COPD more active after pulmonary rehabilitation? Chest 2008;134:273–80.
Wewel AR, Gellermann I, Schwertfeger I, et al. Intervention by phone calls raises domiciliary activity and exercise capacity in patients with severe COPD. Respir Med 2008;102:20–6.
O’Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832–40.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Magnussen, H., Waschki, B. & Watz, H. Die Messung der körperlichen Aktivität von Patienten mit chronisch-obstruktiver Bronchitis und Lungenemphysem. Med Klin 104, 303–308 (2009). https://doi.org/10.1007/s00063-009-1052-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-009-1052-4